NCT06088810

Brief Summary

The primary purpose of this Stage 1b NIH-funded clinical trial (K23AG073618, PI Petrovsky) is to determine the efficacy of a 1-month music intervention (Calming Music Personalized for Sleep Enhancement in PeRsons living with Dementia, CoMPoSER) on health outcomes in 72 dyads (144 participants) of persons living with dementia (PLWD) and their caregivers (Stage 1b). The secondary purpose of this research project is to examine the mechanism of stress reduction and sustained effects of the music intervention on PLWD and caregiver well-being. We will evaluate the acceptability of the mobile application CoMPoSER in a pilot RCT and determine the impact of the mobile application CoMPoSER on PLWD (sleep latency, sleep efficiency, wake after sleep onset, total sleep time, sleep quality) and caregiver (perceived stress and well-being) outcomes.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
144

participants targeted

Target at P75+ for not_applicable

Timeline
4mo left

Started Feb 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress45%
Feb 2026Aug 2026

First Submitted

Initial submission to the registry

September 26, 2023

Completed
22 days until next milestone

First Posted

Study publicly available on registry

October 18, 2023

Completed
2.3 years until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

January 29, 2026

Status Verified

January 1, 2026

Enrollment Period

6 months

First QC Date

September 26, 2023

Last Update Submit

January 27, 2026

Conditions

Keywords

Dementia

Outcome Measures

Primary Outcomes (1)

  • Acceptability

    At least 80% of the dyads will find the intervention acceptable

    4 weeks

Secondary Outcomes (6)

  • PLWD Objective Sleep Outcomes

    1 month, 3 months

  • PLWD Subjective Sleep Outcomes

    1 month, 3 months

  • Caregiver Stress Outcome

    1 month, 3 months

  • Caregiver Wellbeing Outcome (Burden)

    1 month, 3 months

  • Caregiver Wellbeing Outcome (Depression)

    1 month, 3 months

  • +1 more secondary outcomes

Study Arms (2)

Sleep Education Group

ACTIVE COMPARATOR

Participants in this group will receive sleep education.

Other: Sleep Education

CoMPoSER Intervention Group

EXPERIMENTAL

Participants in this group will use a mobile application that plays calming music personalized for sleep enhancement.

Other: CoMPoSER intervention group

Interventions

Participants in the intervention will use a mobile application that plays calming music personalized for sleep enhancement, relaxation techniques and nighttime routine guidance.

CoMPoSER Intervention Group

Participants in this intervention will receive sleep education based on the NIH/NIA guide, which includes tips for getting a good night's sleep.

Sleep Education Group

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 60 and above
  • Existing physician diagnosis of dementia or self-reported memory impairment and Clinical Dementia Rating Scale score of greater than 0.5,
  • Score of \>10 on the Insomnia Severity Index
  • Stable dose of psychotropic medications
  • Agreeing to wear an actiwatch for the duration of the study

You may not qualify if:

  • Hearing impairment
  • Planned transition to a residential or institutional care facility in 3 months
  • Presence of extrapyramidal symptoms or acute sleep disruption
  • Bed bound
  • Living in an alternative home setting (such as Assisted Living Community)
  • Age 18 and above.
  • Providing at least 4 hours of daily care
  • Living with PLWD
  • Able to read and communicate in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (6)

  • Vitiello MV, Borson S. Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment. CNS Drugs. 2001;15(10):777-96. doi: 10.2165/00023210-200115100-00004.

    PMID: 11602004BACKGROUND
  • Petrovsky DV, Ramesh P, McPhillips MV, Hodgson NA. Effects of music interventions on sleep in older adults: A systematic review. Geriatr Nurs. 2021 Jul-Aug;42(4):869-879. doi: 10.1016/j.gerinurse.2021.04.014. Epub 2021 Jun 2.

    PMID: 34090233BACKGROUND
  • Cheour S, Cheour C, Kilani C, Guemri A, Zineddine D, Khelifa R, Supriya R, Bragazzi NL, Cheour F, Baker JS, Gaied-Chortane S. Salivary Testosterone and Cortisol Levels in Tunisian Elderly Male Patients With Mild Alzheimer's Disease. Implications of Musical Therapy And/Or Physical Rehabilitation. Front Physiol. 2022 Aug 5;13:839099. doi: 10.3389/fphys.2022.839099. eCollection 2022.

    PMID: 35991172BACKGROUND
  • Takahashi T, Matsushita H. Long-term effects of music therapy on elderly with moderate/severe dementia. J Music Ther. 2006 Winter;43(4):317-33. doi: 10.1093/jmt/43.4.317.

    PMID: 17348758BACKGROUND
  • Gooneratne NS, Vitiello MV. Sleep in older adults: normative changes, sleep disorders, and treatment options. Clin Geriatr Med. 2014 Aug;30(3):591-627. doi: 10.1016/j.cger.2014.04.007. Epub 2014 Jun 12.

    PMID: 25037297BACKGROUND
  • Shum A, Taylor BJ, Thayala J, Chan MF. The effects of sedative music on sleep quality of older community-dwelling adults in Singapore. Complement Ther Med. 2014 Feb;22(1):49-56. doi: 10.1016/j.ctim.2013.11.003. Epub 2013 Nov 14.

    PMID: 24559816BACKGROUND

MeSH Terms

Conditions

Dementia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Darina Petrovsky

    Duke University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The study will consist of 144 participants (72 dyads). Dyads will receive 4 weekly phone calls in addition to the baseline and post-intervention in-person home visits. Those receiving the CoMPoSER intervention will undergo the following components: A) relaxation techniques; B) meaningful and relaxing music playlist, tailored to PLWD preferred genre, and C) nighttime routine guidance. Those undergoing the attention control intervention will receive sleep education. The attention control design includes participants finding their own treatment if assigned to no-treatment group and higher study dropout rates.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 26, 2023

First Posted

October 18, 2023

Study Start

February 1, 2026

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

January 29, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share